{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=aripiprazole+tablets", "query": { "intervention": "aripiprazole tablets" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 61, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=aripiprazole+tablets&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-08T22:35:11.762Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00110461", "title": "Aripiprazole in Children and Adolescents With Bipolar I Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "10 Years to 17 Years" }, "enrollment_count": 296, "start_date": "2005-03", "completion_date": "2007-02", "has_results": true, "last_update_posted_date": "2012-05-21", "last_synced_at": "2026-09-08T22:35:11.762Z", "location_count": 53, "location_summary": "Scottsdale, Arizona • Little Rock, Arkansas • National City, California + 50 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "National City", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00110461" }, { "nct_id": "NCT02960763", "title": "Optimizing Outcomes of Treatment-Resistant Depression in Older Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Treatment Resistant Depression", "Major Depressive Disorder", "Treatment-Refractory Depression", "Late Life Depression", "Geriatric Depression" ], "interventions": [ { "name": "Aripiprazole Augmentation", "type": "DRUG" }, { "name": "Bupropion Augmentation", "type": "DRUG" }, { "name": "Switch to bupropion", "type": "DRUG" }, { "name": "Lithium Augmentation", "type": "DRUG" }, { "name": "Switch to nortriptyline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 742, "start_date": "2017-02-24", "completion_date": "2021-09-01", "has_results": true, "last_update_posted_date": "2024-10-03", "last_synced_at": "2026-09-08T22:35:11.762Z", "location_count": 4, "location_summary": "Los Angeles, California • St Louis, Missouri • New York, New York + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02960763" }, { "nct_id": "NCT00097266", "title": "Study of Aripiprazole in Patients With Acute Bipolar Mania", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Haloperidol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 615, "start_date": "2004-12", "completion_date": "2007-01", "has_results": false, "last_update_posted_date": "2013-11-08", "last_synced_at": "2026-09-08T22:35:11.762Z", "location_count": 15, "location_summary": "Anaheim, California • Cerritos, California • Garden Grove, California + 12 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "Pico Rivera", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00097266" }, { "nct_id": "NCT01418352", "title": "Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tourette's Disorder" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "7 Years to 17 Years" }, "enrollment_count": 83, "start_date": "2011-08-02", "completion_date": "2014-03-12", "has_results": true, "last_update_posted_date": "2021-10-07", "last_synced_at": "2026-09-08T22:35:11.762Z", "location_count": 13, "location_summary": "Dothan, Alabama • San Francisco, California • Gainesville, Florida + 9 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01418352" }, { "nct_id": "NCT00082199", "title": "Study of Aripiprazole in Subjects With Alcoholism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Alcoholism" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 400, "start_date": "2004-04", "completion_date": "2005-08", "has_results": false, "last_update_posted_date": "2013-11-11", "last_synced_at": "2026-09-08T22:35:11.762Z", "location_count": 14, "location_summary": "Farmington, Connecticut • New Haven, Connecticut • Indianapolis, Indiana + 11 more", "locations": [ { "city": "Farmington", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00082199" }, { "nct_id": "NCT01416441", "title": "Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tourette's Disorder" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "7 Years to 18 Years" }, "enrollment_count": 170, "start_date": "2011-10-19", "completion_date": "2014-03-13", "has_results": true, "last_update_posted_date": "2021-10-07", "last_synced_at": "2026-09-08T22:35:11.762Z", "location_count": 36, "location_summary": "Dothan, Alabama • Little Rock, Arkansas • Los Angeles, California + 31 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01416441" }, { "nct_id": "NCT01727700", "title": "Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tourette's Disorder", "Tic Disorder" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "7 Years to 17 Years" }, "enrollment_count": 133, "start_date": "2012-11", "completion_date": "2013-09", "has_results": true, "last_update_posted_date": "2015-02-13", "last_synced_at": "2026-09-08T22:35:11.762Z", "location_count": 55, "location_summary": "Dothan, Alabama • Goodyear, Arizona • Tucson, Arizona + 52 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Corona", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01727700" }, { "nct_id": "NCT00337571", "title": "Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Behavioral Symptoms", "Autistic Disorder" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 218, "start_date": "2006-06-01", "completion_date": "2008-06-01", "has_results": true, "last_update_posted_date": "2026-05-13", "last_synced_at": "2026-09-08T22:35:11.762Z", "location_count": 31, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Phoenix, Arizona + 28 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00337571" }, { "nct_id": "NCT01129674", "title": "A Long-Term, Open-Label, Study on Schizophrenia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "LY2140023", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 1210, "start_date": "2010-06", "completion_date": "2012-10", "has_results": false, "last_update_posted_date": "2013-01-21", "last_synced_at": "2026-09-08T22:35:11.762Z", "location_count": 42, "location_summary": "Little Rock, Arkansas • Escondido, California • Garden Grove, California + 39 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Escondido", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "National City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01129674" }, { "nct_id": "NCT00332241", "title": "Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Autistic Disorder" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 98, "start_date": "2006-06-01", "completion_date": "2008-04-01", "has_results": true, "last_update_posted_date": "2026-05-13", "last_synced_at": "2026-09-08T22:35:11.762Z", "location_count": 9, "location_summary": "Boca Raton, Florida • Atlanta, Georgia • Louisville, Kentucky + 6 more", "locations": [ { "city": "Boca Raton", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Bloomfield Hills", "state": "Michigan" }, { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT00332241" } ] }